title: The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging.
abstract: OBJECTIVE
  Although incidence rates for mild cognitive impairment (MCI) have been reported, few studies were specifically designed to measure the incidence of MCI and its subtypes using published criteria. We estimated the incidence of amnestic MCI (aMCI) and nonamnestic MCI (naMCI) in men and women separately.
  
  
  METHODS
  A population-based prospective cohort of Olmsted County, MN, residents ages 70-89 years on October 1, 2004, underwent baseline and 15-month interval evaluations that included the Clinical Dementia Rating scale, a neurologic evaluation, and neuropsychological testing. A panel of examiners blinded to previous diagnoses reviewed data at each serial evaluation to assess cognitive status according to published criteria.
  
  
  RESULTS
  Among 1,450 subjects who were cognitively normal at baseline, 296 developed MCI. The age- and sex-standardized incidence rate of MCI was 63.6 (per 1,000 person-years) overall, and was higher in men (72.4) than women (57.3) and for aMCI (37.7) than naMCI (14.7). The incidence rate of aMCI was higher for men (43.9) than women (33.3), and for subjects with ≤12 years of education (42.6) than higher education (32.5). The risk of naMCI was also higher for men (20.0) than women (10.9) and for subjects with ≤12 years of education (20.3) than higher education (10.2).
  
  
  CONCLUSIONS
  The incidence rates for MCI are substantial. Differences in incidence rates by clinical subtype and by sex suggest that risk factors for MCI should be investigated separately for aMCI and naMCI, and in men and women.
authors.affiliation: Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, USA. roberts.rosebud@mayo.edu
authors.forename: R O
authors.initials: RO
authors.lastname: Roberts
authors.forename: Y E
authors.initials: YE
authors.lastname: Geda
authors.forename: D S
authors.initials: DS
authors.lastname: Knopman
authors.forename: R H
authors.initials: RH
authors.lastname: Cha
authors.forename: V S
authors.initials: VS
authors.lastname: Pankratz
authors.forename: B F
authors.initials: BF
authors.lastname: Boeve
authors.forename: E G
authors.initials: EG
authors.lastname: Tangalos
authors.forename: R J
authors.initials: RJ
authors.lastname: Ivnik
authors.forename: W A
authors.initials: WA
authors.lastname: Rocca
authors.forename: R C
authors.initials: RC
authors.lastname: Petersen
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D060825:Cognitive Dysfunction / Q000145:classification / Q000453:epidemiology* / Q000523:psychology; D015331:Cohort Studies; D004522:Educational Status; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008569:Memory Disorders / Q000453:epidemiology / Q000523:psychology; D008910:Minnesota / Q000453:epidemiology; D009483:Neuropsychological Tests; D011153:Population; D011446:Prospective Studies; D012307:Risk Factors; D012737:Sex Factors; D012959:Socioeconomic Factors